These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 23466817)

  • 41. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TP53 gene mutations are rare in nondysplastic Barrett's esophagus.
    Novotna K; Trkova M; Pazdro A; Smejkal M; Soukupova A; Kodetova D; Smejkal P; Sedlacek Z
    Dig Dis Sci; 2006 Jan; 51(1):110-3. PubMed ID: 16416221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
    World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.
    Doak SH; Jenkins GJ; Parry EM; D'Souza FR; Griffiths AP; Toffazal N; Shah V; Baxter JN; Parry JM
    Gut; 2003 May; 52(5):623-8. PubMed ID: 12692043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.
    Reid BJ; Prevo LJ; Galipeau PC; Sanchez CA; Longton G; Levine DS; Blount PL; Rabinovitch PS
    Am J Gastroenterol; 2001 Oct; 96(10):2839-48. PubMed ID: 11693316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus.
    Cabibi D; Caruso S; Bazan V; Castiglia M; Bronte G; Ingrao S; Fanale D; Cangemi A; Calò V; Listì A; Incorvaia L; Galvano A; Pantuso G; Fiorentino E; Castorina S; Russo A
    Oncotarget; 2016 Jul; 7(30):47821-47830. PubMed ID: 27374102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.
    Varghese S; Newton R; Ross-Innes CS; Lao-Sirieix P; Krishnadath KK; O'Donovan M; Novelli M; Wernisch L; Bergman J; Fitzgerald RC
    Gastroenterology; 2015 Nov; 149(6):1511-1518.e5. PubMed ID: 26248086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
    Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.
    Nguyen GH; Schetter AJ; Chou DB; Bowman ED; Zhao R; Hawkes JE; Mathé EA; Kumamoto K; Zhao Y; Budhu A; Hagiwara N; Wang XW; Miyashita M; Casson AG; Harris CC
    Clin Cancer Res; 2010 Dec; 16(23):5824-34. PubMed ID: 20947516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
    J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Karyometry in Barrett's esophagus.
    da Silva VD; Prolla JC; Sharma P; Sampliner R; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 2001 Feb; 23(1):40-6. PubMed ID: 11233742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
    Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
    Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue.
    Giménez A; Minguela A; de Haro LM; Parrilla P; Bermejo J; Pérez D; García AM; Ortiz MA; Molina J; Alvarez R
    World J Surg; 2000 Jan; 24(1):72-7. PubMed ID: 10594207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.
    Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J
    J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.